Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3. - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Journal of Virology Année : 2006

Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3.

Résumé

Mechanisms of cellular transformation associated with human papillomavirus type 5 (HPV5), which is responsible for skin carcinomas in epidermodysplasia verruciformis (EV) patients, are poorly understood. Using a yeast two-hybrid screening and molecular and cellular biology experiments, we found that HPV5 oncoprotein E6 interacts with SMAD3, a key component in the transforming growth factor beta1 (TGF-beta1) signaling pathway. HPV5 E6 inhibits SMAD3 transactivation by destabilizing the SMAD3/SMAD4 complex and inducing the degradation of both proteins. Interestingly, the E6 protein of nononcogenic EV HPV9 failed to interact with SMAD3, suggesting that downregulation of the TGF-beta1 signaling pathway could be a determinant in HPV5 skin carcinogenesis.

Domaines

Virologie
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

pasteur-00175413 , version 1 (31-10-2008)

Identifiants

Citer

Jose-Andres Mendoza, Yves Jacob, Patricia Cassonnet, Michel Favre. Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3.. Journal of Virology, 2006, 80 (24), pp.12420-4. ⟨10.1128/JVI.02576-05⟩. ⟨pasteur-00175413⟩

Collections

PASTEUR
38 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More